Abstract
The incidence of breast cancer in the US is known to be higher among white than black women and among women of higher socioeconomic status (SES), but once a woman, either black or white, has the disease, she is more likely to have a recurrence and to die of breast cancer if she is of lower socioeconomic status. Explanations for these observed differences are varied and inconsistent making it clear that these reported differentials are not sufficiently understood. In understanding breast cancer in a multicultural setting, delay in diagnosis, follow-up, and treatment are frequently the focus of attention. However these factors do not sufficiently explain the observed differences between blacks and whites. A review of recent literature reveals an increasing focus on the role of SES in breast cancer etiology and progression; however, the confounding of SES with race/ethnicity (black vs. white) contributes to the insufficient understanding of the effect of these two factors. This report will focus on the interplay between race/ethnicity and SES and their relative effects upon analyses of survival from breast cancer. Findings are based on prospective clinical trial data. SES factors have been associated with most of the known or suspected risk factors for breast cancer incidence and progression. In addition to race/ethnicity, SES is also associated with diet, lifestyle factors, physical characteristics, and tumor characteristics. Without controlling for other risk factors, the ratios of risk for blacks with respect to whites for disease-free survival and overall survival were 1.30 (95% CI: 1.04–1.61) and 1.42 (95% CI: 1.15–1.76), respectively. However, after controlling for patient risk factors, such as the number of positive lymph nodes, tumor diameter, estrogen receptor status and socioeconomic factors, these differences decrease and are not statistically significant. Socioeconomic status is associated both with race/ethnicity and estrogen receptor status. A loglinear analysis demonstrates that the apparent association of race/ethnicity with estrogen receptor status is mediated by socioeconomic status. An implication of this finding is that environmental and lifestyle components rather than genetic factors associated with race may explain the observed differentials between black and white breast cancer patients. Knowledge of environmental factors associated with SES have the potential for providing important clues about the prevention and control of breast cancer.
Similar content being viewed by others
References
Howe HL, Wingo PA, Thun MJ, Ries LAG, Rosenberg HM, Feigal EG, Edwards BK: Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. Journal of the National Cancer Institute 93: 824-842, 2001
Krieger N: Social class and the black/white crossover in the age-specific incidence of breast cancer: A study linking census-derived data to populations-based registry records. American Journal of Epidemiology 131: 804-814, 1990
Gordon NH, Crowe JP, Brumberg DJ, Berger NA: Socioeconomic factors and race in breast cancer recurrence and survival. American Journal of Epidemiology 135: 609-618, 1992
Gordon NH: The association of education and income with estrogen receptor status in primary breast cancer. American Journal of Epidemiology 142: 796-803, 1995
Bain RP, Greenberg RS. Whitaker JP: Racial differences in survival of women with breast cancer. J Chronic Dis 39: 631-642, 1986
Bassett MT, Krieger N: Social class and black-white differences in breast cancer survival. Am J Public Health 76: 1400-1403, 1986
Berg JW, Ross R, Latourette HB: Economic status and survival of cancer patients. Cancer 39: 467-477, 1977
Crowe JP, Gordon NH, Hubay CA, Pearson OH, Marshall JS, McGuire WL: The interaction of estrogen receptor status and race in predicting prognosis for stage I breast cancer patients. Surgery 100: 99-105, 1986
Dansey RD, Hessel PA, Browde S, Lange M, Derman D, Nissenbaum M, Bezwoda WR: Lack of a significant independent effect of race on survival in breast cancer. Cancer 61: 1908-1912, 1988
Dayal HH, Power RN, Chiu C: Race and socioeconomic status in survival from breast cancer. J Chronic Dis 35: 675-683, 1981
Gregorio DI, Cummings KM, Michalek A: Delay, stage of disease, and survival among white and black women with breast cancer. Am J Public Health 73: 590-593, 1983
Natarajan N, Nemoto T, Mettlin C, Murphy GP: Race related differences in breast cancer patients. Cancer 56: 1704-1709, 1984
Nemoto T, Vana J, Bedwani R, Baker HW, McGregor FH, Murphy GP: Management and survival of female breast cancer results of a national survey by the American College of Surgeons. Cancer 45: 2917-2924, 1980
Notani PN, Varma AO, Leske MC, Janerich DT: Breast cancer in NewYork State. NY State J Med 82: 1044-1049, 1980
Stanford JL, Greenberg RS: Breast cancer incidence in young women by estrogen receptor status and race. Am J Public Health 79: 71-73, 1989
Valanis B, Wirman J, Hertzberg VS: Social and biological factors in relation to survival among black vs. white women with breast cancer. Breast Cancer Res Treat 9: 135-143, 1987
Vernon SW, Tilley BC, Neale AV, Steinfeldt L: Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer. Cancer 55: 1563-1567, 1985
McWhorter WP, Mayer WJ: black/white differences in type of initial breast cancer treatment and implications for survival. Am 1 Public Health 77: 1515-1517, 1987
Wilson RE, Donegan WL, Mettlin C, Natarajan N, Smart CR, Murphy GP: The 1992 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet 159: 309-318, 1984
Bacquet CR, Commiskey P: Socioeconomic factors and breast carcinoma in multicultural women. Cancer 88: 1256-1264, 2000
Yood MU, Johnson CC, Blount A, Abrams J, Wolman Em McCarthy BD, Raju U, Nathanson DS, Worsham M, Wolman SR: Race and differences in breast cancer survival in a managed care population. Journal of the National Cancer Institute 17: 1487-1491, 2000
Ansell D, Whitman S, Lipton R, Cooper R: Race, income, and survival from breast cancer at two public hospitals. Cancer 72: 2974-2978, 1993
Coates RJ, Bransfield DD, Wesley M, Hankey B, Eley JW, Greenberg RS, Flanders D, Hunter CP, Edwards BK, Forman M: Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. Journal of the National Cancer Institute 84: 938-950, 1992
Hunter CP, Redmond CK, Chen VW, Austin DF, Greenberg RS, Correa P, Muss HB, Forman MR, Wesley MN, blacklow RS: Breast cancer: Factors associated with stage at diagnosis in black and white women. black/white Cancer Survival Study Group. Journal of the National Cancer Institute 85: 1129-1137, 1993
Breen N, Wesley MN, Merrill RM, Johnson K: The relationship of socio-economic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute black-white Cancer Survival Study. Ethnicity and Disease 9: 111-125, 1999
Kogevinas M, Porta M. Socioeconomic differences in cancer survival: A reviewof the evidence. IARC Scientific Publications 138: 177-206, 1997
Joslyn SA, West MM: Racial differences in breast carcinoma survival. Cancer 88: 114-123, 2000
Mitra NK, Rush BF, Verner EA: Comparative study of breast cancer in the black and white populations of two inner-city hospitals. J Sung Oncol 15: 11-17, 1980
Ownby HE, Frederick J, Russo J, Brooks SC, Swanson GM, Heppner GH, Brennan MJ: Racial differences in breast cancer patients. J Nail Cancer Inst 75: 55-60, 1985
Ownby HE, Brooks SC. Re: Hormonal and personal effects on estrogen receptors in breast cancer. (Letter). Am J Epidemiol 123: 1118-1119, 1986
Pegoraro RJ, Kaman V, Nirmul D, Joubert SM: Estrogen and progesterone receptors in breast cancer among women of different racial groups. Cancer Res 46: 2117-2120, 1986
Briele HA Jr, Walker MJ, Wild L, Wood DK, Greager JA, Schneebaum S, Silva-Lopez E, Han MC, Gunter T, Das Gupta TK: Results of treatment of stage I-III breast cancer in black Americans. The Cook County Hospital experience, 1973-1987. Cancer 65: 1062-1071, 1990
Moormeier J: Breast cancer in black women. Annals of Internal Medicine 124: 897-905, 1996
Chen VW, Correa P, Kurman RJ, Wu XC, Eley JW, Austin D, Muss H, Hunter CP, Redmond C, Sobhan M: Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiology, Biomarkers and Prevention 3: 127-135, 1994
Mohla S, Sampson CC, Kahn T, Enterline JP, Leffall L Jr, White JE: Estrogen and progesterone receptors in breast cancer in black Americans. Cancer 50: 552-559, 1982
Beverly LN, Flanders WD, Go RCP, Soong SJ: 4 comparison of estrogen and progesterone receptors in black and white breast cancer patients. Am J Public Health 77: 351-353, 1987
Savage N, Levin J, De Moor NG, Lange M: Cytosolic oestrogen receptor content of breast cancer tissue in blacks and whites. S Afr Med J 59: 623-624, 1981
Schwartz MR, Randolph RL, Panko WB: Carcinoembryonic antigen and steroid receptors in the cytosol of carcinoma of the breast. Cancer 55: 2464-2471, 1985
Hacking EA, Dent DM, Gudgeon CA: Malignant tumors of the breast. S Afr Med J 63: 323, 1984
Aziz H, Hussain F, Sohn C, Mediavillo R, Saitta A, Hussain A, Brandys M, Homel P, Rotman M: Early onset of breast carcinoma in African American women with poor prognostic factor. American Journal of Clinical Oncology 22: 436-440, 1999
Farley TA, Flannery JT: Late-stage diagnosis of breast cancer in women of lower socioeconomic status: Public health implications. Am J Public Health 79: 1508-1512, 1989
Hunter CP: Epidemiology, stage of diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populations. Cancer 88: 1193-1202, 2000
Jones BA, Kasi SV, Curnen MG, Owens PH, Dubrow R: Severe obesity as an explanatory factor for the black/white difference in stage at diagnosis of breast cancer. American Journal of Epidemilogy 146: 3949404, 1997
Browne D, Romilly-Harper AP: National action plan on breast cancer workshop on multicultural aspects of breast cancer etiology-Recommendtions of the workshop. Cancer 88: 1272-1276, 2000
Habel LA, Stanford JL: Hormone receptors and breast cancer. Epidemiol Rev 15: 209-219, 1993
Hubay CA, Gordon NH, Pearson OH, Marshall JS, McGuire WL: Eight-year follow-up of adjuvant therapy for stage 11 breast cancer. World J Surg 9: 738-749, 1985
Pearson OH, Hubay CA, Gordon NH, Marshall JS, Crowe JP, Arafah BM, McGuire WL: Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage 11 estrogen receptor-positive breast cancer. Cancer 64: 1819-1823, 1989
National Center for Health Statistics. Vital statistic of the United States 1980. Vol. 2-mortality, part A. Hyattsville, MD: National Cancer for Health Statistics, 1980
Use of race and ethnicity in public health surveillance: Summary of the CDC/ATSDR workshop. MMWR 42(no.19,RR-10):1-16, 1993
Ries LA, Hankey BF, Edwards BK (eds), Cancer statistics review, 1973-1986. Bethesda, MD: Surveillance Program, Division of Cancer Prevention and Control, National Cancer Institute, 1989 (Publication no. 89-27-89)
Gray GE, Henderson BE, Pike MC: Changing ratio of breast cancer incidence rates with age of black females compared with white females in the US. J Natl Cancer Inst 64: 461-463, 1980
National Center for Health Statistics. Vital statistics of the United States 1980. Vol 2-Mortality, part A. Hyattsville, MD: National Center for Health Statistics, 1980 (Publication no. 85-11-01)
Cox DR: Regression models and life tables (with discussion). J R Stat Soc B 34: 187-220, 1972
Agresti A: Categorical data analysis. John Wiley and Sons, Inc., NewYork, NY, 1990
Block G, Sorenson:. Vitamin C intake and dietary sources by demographic characteristics. Nutr Cancer 10: 53-65, 1987
Fehily AM, Phillips KM, Yarnell JWG: Diet, smoking, social class, and body mass index in the Caerphilly Heart Disease Study. Am J Clin Nutr 40: 827-833, 1984
Kelsey JL: Breast cancer epidemiology: Summary and future directions. Epidemiol Rev 15: 256-263, 1993
Kushi LH, Folsom AR, Jacobs DR, Luepker RV, Elmer PJ, Blackburn H: Educational attainment and nutrient consumption patterns: The Minnesota Heart Survey. 1 Am Diet Assoc 88: 1230-1236, 1988
Rimm IJ, Rimm AA: Association between socioeconomic status and obesity in 59,556 women. Prev Med 3: 543-572, 1974
Rolland-Cachera MF, Bellisle F: No correlation between adiposity and food intake: Why are working class children fatter? Am J Clin Nutr 44: 779-787, 1986 64 Gordon
Adlercreutz H, Mousavi Y, Hockerstedt K: Diet and breast cancer. Acta Oncol 31: 175-181, 1992
Carroll KK, Parenteau JI: A proposed mechanism for effects of diet on mammary cancer. Nutr Cancer 16: 79-83, 1991
Goldin BR, Adlercreutz H, Gorbach SL, Woods MN, Dwyer JT, Conlon T, Bohn E, Gershoff SN: The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr 44: 945-953, 1986
Williams CM, Dickerson JWT: Dietary fat, hormones and breast cancer: The cell membrane as a possible site of interaction of these two risk factors. Eur J Surg Oncol 13: 89-104, 1987
Korner W, Hanf V, Schuller W, Kempter C, Metzger J, Hagenmaier H: Developmentof a sensitive E-screen assay for quantitative analysis of estrogenic activity in municipal sewage plant effluents. Science of the Total Environment 225: 33-48, 1999
Adler NE, Boyce T, Chesney MA, Cohen S, Folkman S, Kahn RL, Syme SL: Socioeconomic status and health. Am Psychol 49: 15-24, 1994
Hakama M, Hakulinen T, Pukkala E, et al.: Risk indicators of breast and cervical cancer on ecologic and individual levels. Am I Epidemiol 116: 990-1000, 1982
Millikan R, DeVoto E, Duell EJ, Tse CK, Savitz DA, Beach J, Edmiston S, Jackson S, Newman B: Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiology, Biomarkers and Prevention 9: 1233-1240, 2000
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gordon, N.H. Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 22, 55–65 (2003). https://doi.org/10.1023/A:1022212018158
Issue Date:
DOI: https://doi.org/10.1023/A:1022212018158